Cancer Stem Cells in Acute Leukemia

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

NCT01653613 ·Status: UNKNOWN

Biology Studies of Hematologic Cancers

NCT00923442 ·Status: ENROLLING_BY_INVITATION

Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia

NCT01079507 ·Status: UNKNOWN

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

NCT04060485 ·Status: UNKNOWN

Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder

NCT01511575 ·Status: COMPLETED

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

NCT05588154 ·Status: RECRUITING

Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors

NCT01987726 ·Status: COMPLETED

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592 ·Status: RECRUITING

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

NCT04985357 ·Status: WITHDRAWN

Evaluation of ClearLLab LS Screening Panel

NCT05819762 ·Status: COMPLETED

Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

NCT00005619 ·Status: COMPLETED

Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia

NCT01016379 ·Status: COMPLETED

Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia

NCT01139307 ·Status: COMPLETED

Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

NCT01520246 ·Status: COMPLETED

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

NCT00897936 ·Status: COMPLETED

Identifying Molecular Drivers of Cancer

NCT02470715 ·Status: COMPLETED

Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia

NCT02330718 ·Status: UNKNOWN

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198 ·Status: COMPLETED

Collection of Blood, Bone Marrow, Tumor or Tissue Samples

NCT00043615 ·Status: COMPLETED

S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma

NCT01563861 ·Status: COMPLETED

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

NCT00039676 ·Status: ACTIVE_NOT_RECRUITING

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

NCT02688517 ·Status: RECRUITING

Screening Study for Participants With Malignant Tumors

NCT05419375 ·Status: COMPLETED ·Phase: PHASE2

Prognostic Factors for All Types of Cancer Combined

NCT00704587 ·Status: COMPLETED

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

NCT05530759 ·Status: RECRUITING